[go: up one dir, main page]

AU2001227815A1 - Chemically specific imaging of tissue - Google Patents

Chemically specific imaging of tissue

Info

Publication number
AU2001227815A1
AU2001227815A1 AU2001227815A AU2781501A AU2001227815A1 AU 2001227815 A1 AU2001227815 A1 AU 2001227815A1 AU 2001227815 A AU2001227815 A AU 2001227815A AU 2781501 A AU2781501 A AU 2781501A AU 2001227815 A1 AU2001227815 A1 AU 2001227815A1
Authority
AU
Australia
Prior art keywords
tissue
specific imaging
chemically specific
chemically
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001227815A
Inventor
Joseph Chaiken
Charles M. Peterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LighTouch Medical Inc
Original Assignee
LighTouch Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LighTouch Medical Inc filed Critical LighTouch Medical Inc
Publication of AU2001227815A1 publication Critical patent/AU2001227815A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65—Raman scattering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AU2001227815A 2000-01-13 2001-01-10 Chemically specific imaging of tissue Abandoned AU2001227815A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09482413 2000-01-13
US09/482,413 US6503478B2 (en) 1999-01-13 2000-01-13 Chemically specific imaging of tissue
PCT/US2001/000832 WO2001051094A1 (en) 2000-01-13 2001-01-10 Diagnostic method using a deuterated agent for imaging specific tissue

Publications (1)

Publication Number Publication Date
AU2001227815A1 true AU2001227815A1 (en) 2001-07-24

Family

ID=23915970

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001227815A Abandoned AU2001227815A1 (en) 2000-01-13 2001-01-10 Chemically specific imaging of tissue

Country Status (3)

Country Link
US (1) US6503478B2 (en)
AU (1) AU2001227815A1 (en)
WO (1) WO2001051094A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002001242A2 (en) * 2000-06-28 2002-01-03 The Regents Of The University Of Minnesota Imaging methods for visualizing implanted living cells
US6870612B2 (en) * 2002-01-22 2005-03-22 Spectracode, Inc. Portable spectral imaging microscope system
US6907149B2 (en) * 2002-02-01 2005-06-14 Kaiser Optical Systems, Inc. Compact optical measurement probe
GB0215769D0 (en) * 2002-07-08 2002-08-14 Ic Innovations Ltd A method of studying living cells
US7010339B2 (en) * 2002-07-29 2006-03-07 The United States Of America As Represented By The Secretary Of The Navy Hybrid lidar-radar for medical diagnostics
WO2004042360A2 (en) * 2002-11-04 2004-05-21 The Regents Of The Univeristy Of California Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
WO2005031301A2 (en) * 2003-07-10 2005-04-07 Parallax Biosystems, Inc. Raman signature probes and their use in the detection and imaging of molecular processes and structures
EP1699351B1 (en) * 2003-12-22 2011-05-04 Lightouch Medical, Inc. Process for determination of cell viability
US8540968B2 (en) * 2004-03-02 2013-09-24 Cellectar, Inc. Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
ATE437657T1 (en) * 2004-03-02 2009-08-15 Cellectar Inc PHOSPHOLIPIDE ANALOGUES FOR THE TREATMENT OF CANCER
WO2006037036A2 (en) * 2004-09-27 2006-04-06 Purdue Research Foundation Quantitative proteomics with isotopic substituted raman active labeling
JP5001934B2 (en) * 2005-04-15 2012-08-15 バイエル・ヘルスケア・エルエルシー Non-invasive system and method for measuring body glucose
US8452365B2 (en) * 2005-05-25 2013-05-28 Bayer Healthcare Llc Methods of using Raman spectral information in determining analyte concentrations
US7330747B2 (en) * 2005-06-07 2008-02-12 Chemimage Corporation Invasive chemometry
US7330746B2 (en) * 2005-06-07 2008-02-12 Chem Image Corporation Non-invasive biochemical analysis
EP1760440A1 (en) * 2005-08-31 2007-03-07 The Procter and Gamble Company Confocal raman spectroscopy for dermatological studies
US7558619B2 (en) * 2005-10-04 2009-07-07 Nu Skin International, Inc. Raman instrument for measuring weak signals in the presence of strong background fluorescence
GB0604647D0 (en) 2006-03-08 2006-04-19 Shchepinov Mikhail Stabilized food supplements and their derivatives
JP5047962B2 (en) * 2006-07-06 2012-10-10 株式会社疲労科学研究所 Method of operating test / diagnosis apparatus for cancer, systemic lupus erythematosus (SLE) or antiphospholipid antibody syndrome using near infrared light
US7603151B2 (en) * 2006-08-22 2009-10-13 Bayer Healthcare Llc Non-invasive methods of using spectral information in determining analyte concentrations
JP5199256B2 (en) * 2006-08-22 2013-05-15 バイエル・ヘルスケア・エルエルシー Method for correcting spectral images for optical anomalies using software
AU2008254328A1 (en) 2007-05-18 2008-11-27 The Johns Hopkins University A treatment simulator for brain diseases and method of use thereof
WO2009086509A2 (en) 2007-12-27 2009-07-09 Purdue Research Foundation Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy
EP2334621A1 (en) * 2008-09-16 2011-06-22 Concert Pharmaceuticals, Inc. Deuterated 2-amino-3-hydroxypropanoic acid derivatives
US7896498B2 (en) * 2009-03-30 2011-03-01 Ottawa Hospital Research Institute Apparatus and method for optical measurements
SI2440253T1 (en) * 2009-06-12 2020-09-30 Cellectar, Inc. Alkyl phospholipid compounds for treating cancer and imaging and detection of cancer stem cells
US20110064660A1 (en) * 2009-09-11 2011-03-17 Pinchuk Anatoly Deuterated alkyl phospholipid compounds, compositions, and methods of use
WO2011031919A2 (en) * 2009-09-11 2011-03-17 Cellectar, Inc. Non-radioactive phospholipid compounds, compositions, and methods of use
US8538499B2 (en) * 2009-09-23 2013-09-17 Lightouch Medical, Inc. Process and apparatus for non-invasive, continuous in vivo measurement of hematocrit
AU2010313249B2 (en) 2009-10-30 2016-05-19 Biojiva Llc Alleviating oxidative stress disorders with PUFA derivatives
US9662047B2 (en) 2010-08-05 2017-05-30 Massachusetts Institute Of Technology Portable raman diagnostic system
CA2834342C (en) 2011-04-26 2021-08-31 Retrotope, Inc. Impaired energy processing disorders and mitochondrial deficiency
DK2701697T3 (en) 2011-04-26 2020-06-29 Retrotope Inc Oxidative retinal diseases
KR102110175B1 (en) 2011-04-26 2020-05-13 레트로토프 인코포레이티드 Disorders implicating pufa oxidation
US10154983B2 (en) 2011-04-26 2018-12-18 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating PUFAs
CN104294228B (en) * 2014-11-07 2017-02-15 上海纳米技术及应用国家工程研究中心有限公司 Substrate having surface Raman scattering enhancement on glycerol molecules and preparation and application thereof
EP3950649A1 (en) 2015-11-23 2022-02-09 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
KR20210075648A (en) 2019-12-13 2021-06-23 삼성전자주식회사 Compact raman sensor, and apparatus for estimating bio-component using the same
KR20220143931A (en) 2020-02-21 2022-10-25 레트로토프 인코포레이티드 Process for isotopic modification of polyunsaturated fatty acids and derivatives thereof
JP7642437B2 (en) * 2020-05-18 2025-03-10 花王株式会社 Method for evaluating the moisture content of the stratum corneum of the skin
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849458A (en) * 1966-01-21 1974-11-19 Incentive Res & Dev Ab Method for deuterating organic compounds
CA1078865A (en) 1977-07-06 1980-06-03 Grant W. Reader Isotopically labelled fatty acids
WO1989001342A2 (en) * 1987-08-07 1989-02-23 Mallinckrodt, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
US5042488A (en) 1987-09-29 1991-08-27 The Washington University Methods employing deuterium for obtaining direct, observable deuterium magnetic resonance images in vivo and in situ
US4893627A (en) 1988-05-26 1990-01-16 The United States Of America As Represented By The United States Department Of Energy Method for nuclear magnetic resonance imaging using deuterum as a contrast agent
GB8817137D0 (en) 1988-07-19 1988-08-24 Nycomed As Compositions
US5510894A (en) 1988-12-22 1996-04-23 Renishaw Plc Spectroscopic apparatus and methods
US5183042A (en) 1989-05-23 1993-02-02 Vivascan Corporation Electromagnetic method and apparatus to measure constituents of human or animal tissue
US5261410A (en) 1991-02-07 1993-11-16 Alfano Robert R Method for determining if a tissue is a malignant tumor tissue, a benign tumor tissue, or a normal or benign tissue using Raman spectroscopy
DE69231614T2 (en) 1991-02-26 2001-05-03 Massachusetts Institute Of Technology, Cambridge MOLECULAR SPECTROSCOPY METHOD AND DEVICES FOR TISSUE DIAGNOSIS
US5593899A (en) 1993-02-25 1997-01-14 Trustees Of The University Of Pennsylvania Device and method for measuring tissue oxygenation through the skin using oxygen dependent quenching of phosphorescence
US6040906A (en) 1996-07-11 2000-03-21 Harhay; Gregory P. Resonance raman spectroscopy for identifying and quantitating biomatter, organic, and inorganic analytes
US5932562A (en) 1998-05-26 1999-08-03 Washington University Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same

Also Published As

Publication number Publication date
US6503478B2 (en) 2003-01-07
WO2001051094A8 (en) 2001-11-08
WO2001051094A1 (en) 2001-07-19
US20020041848A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU2001227815A1 (en) Chemically specific imaging of tissue
AU2001241963A1 (en) Improved medical procedure
AU7862200A (en) Flip-wing tissue retainer
AU2001288462A1 (en) Medical instrument
AU2001232360A1 (en) Medical instrument
AU2001247535A1 (en) Soft tissue anchor
AU2001273505A1 (en) Single-use radiological imaging aid
AU2001255724A1 (en) Non-invasive tissue characterization
AU2001271749A1 (en) Bone preparation instruments
AU2001229442A1 (en) Improved endoscopic imaging and treatment of anatomic structures
AU2001249832A1 (en) Remote interpretation of medical images
AU2002225912A1 (en) Tissue removal using biocompatible materials
AU2001253170A1 (en) Soft tissue compression shield
AU2002222241A1 (en) Soft tissue implant
AU2001254786A1 (en) Medical implant
AU2001259702A1 (en) Tissue regrafting
AU2002236639A1 (en) Indirect mode imaging
AU2001233208A1 (en) Human sulfatases
AU2001247841A1 (en) Medical procedure
AU6599800A (en) Endoscope
AU2001263101A1 (en) Surgical instrument
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2001288612A1 (en) Human kinases
AU2001268525A1 (en) Human kinases
AU2001238488A1 (en) Human kinases